|
|
|
Insider
Information: |
Cormorant Private Healthcare Fund Ii, Lp |
Relationship: |
|
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
33,608,047 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$98,233,175 |
|
|
Total
Shares |
33,608,047 |
|
|
Total
Value |
$98,233,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avidity Biosciences, Inc. |
RNA |
10% Owner |
2020-06-16 |
0 |
2020-06-16 |
2,514,545 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2020-06-30 |
789,989 |
Premium* |
|
Bioatla, Inc. |
BCAB |
10% Owner |
2020-12-18 |
0 |
2020-12-18 |
2,292,060 |
Premium* |
|
Rain Therapeutics Inc. |
RAIN |
Former 10% Owner |
2021-04-27 |
0 |
2021-04-27 |
2,776,657 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
3,202,200 |
Premium* |
|
Aerovate Therapeutics, Inc. |
AVTE |
Former 10% Owner |
2021-07-02 |
0 |
2021-07-02 |
2,030,691 |
Premium* |
|
Erasca, Inc. |
ERAS |
|
2021-07-20 |
0 |
2022-12-13 |
10,813,246 |
Premium* |
|
GreenLight Biosciences Holdings,... |
GRNA |
|
|
0 |
2023-05-29 |
9,188,659 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GRNA |
GreenLight Biosciences Ho... |
|
|
2023-05-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,188,659 |
|
% |
|
ERAS |
Erasca, Inc. |
|
|
2022-12-13 |
4 |
B |
$6.50 |
$1,999,998 |
I/I |
307,692 |
10,813,246 |
0.01 |
% |
|
ERAS |
Erasca, Inc. |
10% Owner |
|
2021-07-20 |
4 |
B |
$16.00 |
$15,200,000 |
I/I |
950,000 |
10,505,553 |
1.5 |
% |
|
ERAS |
Erasca, Inc. |
10% Owner |
|
2021-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
9,555,553 |
9,555,553 |
0 |
- |
|
AVTE |
Aerovate Therapeutics, In... |
Former 10% Owner |
|
2021-07-02 |
4 |
B |
$14.00 |
$7,000,000 |
I/I |
500,000 |
2,030,691 |
0.01 |
- |
|
AVTE |
Aerovate Therapeutics, In... |
Former 10% Owner |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,530,691 |
1,530,691 |
0 |
- |
|
GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
|
2021-06-28 |
4 |
B |
$19.00 |
$11,400,000 |
I/I |
600,000 |
3,202,200 |
1.5 |
- |
|
GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
|
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,602,200 |
2,602,200 |
0 |
- |
|
RAIN |
Rain Therapeutics Inc. |
Former 10% Owner |
|
2021-04-27 |
4 |
B |
$17.00 |
$7,650,000 |
I/I |
450,000 |
2,776,657 |
0.01 |
- |
|
RAIN |
Rain Therapeutics Inc. |
Former 10% Owner |
|
2021-04-27 |
4 |
A |
$0.00 |
$0 |
I/I |
2,326,657 |
2,326,657 |
0 |
- |
|
BCAB |
Bioatla, Inc. |
10% Owner |
|
2020-12-18 |
4 |
B |
$18.00 |
$14,400,000 |
I/I |
800,000 |
2,292,060 |
1.5 |
- |
|
BCAB |
Bioatla, Inc. |
10% Owner |
|
2020-12-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,492,060 |
1,492,060 |
0 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2020-06-30 |
4 |
B |
$17.00 |
$4,930,000 |
I/I |
290,000 |
789,989 |
1.5 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2020-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
499,989 |
499,989 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
10% Owner |
|
2020-06-16 |
4 |
B |
$18.00 |
$5,400,000 |
I/I |
300,000 |
2,514,545 |
1.5 |
% |
|
RNA |
Avidity Biosciences, Inc. |
10% Owner |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,214,545 |
2,214,545 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|